Clinical Trials Insight: 700026939
Latest Information Update: 20 Aug 2008
Price :
$35 *
At a glance
- Drugs Tacrolimus (Primary)
- Indications Transplant rejection
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Veloxis Pharmaceuticals
- 29 Nov 2007 Status changed to completed.
- 07 Nov 2007 Results have been reported by LifeCycle Pharma.
- 13 Sep 2007 New trial record.